Market Access News | pharmaphorum

News

Regulators have started reviews of GSK's depemokimab, aiming to become the first drug for asthma that can be dosed twice a year.

News

Enhertu gets much-anticipated new FDA approval in breast cancer that expands its label and makes it an earlier option in the treatment pathway.

News

Oncopeptides hopes to reignite growth in multiple myeloma drug Pepaxti after getting reimbursement approval in Italy.

News

AstraZeneca has announced another major investment in Canada, tapping into the country's emergence as a "global hub" for clinical trials.

News

Biogen's new high-dose version of SMA drug Spinraza has started regulatory reviews - but can it help return the drug to growth?

News

A Senate hearing on Robert F Kennedy Jr's nomination as HHS Secretary is set for 29th January, with opposition to Trump's pick seemingly growing.